Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Cancer Prev Res (Phila). 2015 Dec 14;9(2):142–148. doi: 10.1158/1940-6207.CAPR-15-0322

Table 5.

Self-reported adverse events.

Event 2.5 mg QD 2.5 mg Q-MWF 1.0 mg Q-MWF 0.25 mg Q-MWF Pb
Any AE 28 (100%)a 27 (96.4%) 27 (96.4%) 28 (100%) 1.00
Related AEc 17 (60.7%) 10 (35.7%) 20 (71.4%) 18 (64.3%) 0.04
Any SAE 2 (7.1%) 1 (3.6%) 0 (0%) 1 (3.6%) 0.90
a

N (%of total)

b

derived from Fisher’s exact test

c

including possibly, probably and definitely related AEs